Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,238.9
7.0 (0.22%)

 

  • STI Straits Times Index
    3,238.9
    7.0 (0.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,594.8
    1.2 (0.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,326.7
    3.0 (0.01%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,891.3
    -18.5 (-0.64%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,303.3
    161.8 (0.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,128.3
    29.4 (0.48%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,162.2
    22.9 (1.07%)
    Index delayed 20 minutes
  • XAO XAO
    6,898.9
    58.1 (0.85%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,681.9M
  • Value: 1,310.8M
  • Rise: 177
  • Fall: 153
  • Unch: 499

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
SinoCloud0.001-
United Engineers2.700-0.010
YZJ Shipbldg SGD1.000+0.030
SingTel3.180-0.120
Golden Agri-Res0.255+0.010
Rex Intl0.191-0.007
China Star Food0.030+0.002
Tritech0.032+0.003
Ascendas Reit2.890-0.010
Sino Grandness0.044-

World Indices

World Indices
Name Last Change
Nasdaq 8,540.8 +61.8
HSI 26,326.7 +3.0
HSCEI 10,424.8 -2.6
Jakarta 6,128.3 +29.4
Nikkei 225 23,303.3 +161.8
SSE Comp 2,891.3 -18.5
Shanghai A 3,029.3 -19.4
Shanghai B 255.2 -3.0
PSE Comp 0.0
KOSPI 2,162.2 +22.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VIKING THERAPEUTICS INC VIKING THERAPEUTICS INC
Updated on 15 Nov 2019 (End of trading day)
Last (USD): 8.010 Change: +0.020 High: 8.160 Remarks: -
Change (%): +0.25 Low: 7.920
Open 8.120 Yesterday's Close 7.99
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,042,848 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.30531 Trailing EPS (USD) e -0.32615 NAV (USD) b 3.9230
PE a - Trailing PE f - Price / NAV b 2.0418
Dividend (USD) d - Cash In Hand (USD) g 0.4283 Issued & Paid-up Shares c 72,264,000
Dividend Yield (%) d - Price / Cash In Hand g 18.702 Treasury Shares h -
Beta - 75 Daysi 0.191 R-Squared - 75 Days(%)i 0.22 Market Cap (M) 578.835
Beta - 500 Daysi 0.073 R-Squared - 500 Days (%)i 0.01 Enterprise Value (M) 291.496
Piotroski F Score 2 Exchange Code VKTX Par Value ( $ ) n.a.
52 Weeks Volatility (%) 52.55 Free Float (%) 89.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VIKING THERAPEUTICS INC NASDAQ 578.835 - - 2.0418 -
Industry Biotechnology NASDAQ 2,339.439 137.552 138.712 5.3722 0.745
Local Peer AMGEN INC NASDAQ 131,231.478 15.634 16.268 12.0099 2.533
Local Peer GILEAD SCIENCES INC NASDAQ 82,323.311 15.091 30.569 3.9955 3.551
Local Peer CELGENE CORP NASDAQ 78,302.774 19.353 13.317 6.4783 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 53,950.070 25.735 25.166 10.2696 -
Local Peer BIOGEN INC NASDAQ 50,933.363 11.496 9.440 3.6392 -
Local Peer ILLUMINA INC NASDAQ 44,979.795 54.455 46.228 10.1329 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 37,865.336 15.491 17.659 3.6047 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,981.306 309.037 16.310 2.3132 -
Local Peer SEATTLE GENETICS INC NASDAQ 19,666.543 - - 11.0511 -
Local Peer INCYTE CORPORATION NASDAQ 18,674.920 170.558 46.115 7.7089 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 13,479.060 - - 4.3843 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 11,865.105 - 38.230 4.2928 -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), REPLIGEN CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), FIBROGEN INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NATERA INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), EPIZYME INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), VIELA BIO INC (NASDAQ), REGENXBIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ARVINAS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), OPKO HEALTH INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), INTREXON CORP (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), OMEROS CORP (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RETROPHIN INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), TRANSLATE BIO INC (NASDAQ), XBIOTECH INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AGENUS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SYNTHORX INC (NASDAQ), IMMUNOGEN INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), AVROBIO INC (NASDAQ), DERMIRA INC (NASDAQ), MACROGENICS INC (NASDAQ), ARDELYX INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), COMPUGEN (NASDAQ), BELLUS HEALTH INC (NASDAQ), MEDICINOVA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RESTORBIO INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), GERON CORP (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ATHERSYS INC (NASDAQ), CHIASMA INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), AFFIMED N V (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), IVERIC BIO INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IMV INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SESEN BIO INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), CHIMERIX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), NANTKWEST INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), COHBAR INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), SYNLOGIC INC (NASDAQ), VACCINEX INC (NASDAQ), VERASTEM INC (NASDAQ), TREVENA INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VERMILLION INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), EQUILLIUM INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ORGENESIS INC (NASDAQ), CURIS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), INMUNE BIO INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SAVARA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), BIOCARDIA INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SOLIGENIX INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SENESTECH INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), BIOCEPT INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), VAXART INC (NASDAQ), TOCAGEN INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), TROVAGENE INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 20 ORD SHS (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), OCUGEN INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ)
Global Peer CSL ASX 124,695.694 46.478 46.478 16.6635 0.966
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 24,218.966 76.642 22.592 5.1020 0.783
Global Peer SINO BIOPHARM HKEx 140,338.934 13.097 13.517 4.1230 0.656
Global Peer WUXI BIO HKEx 109,791.155 146.993 114.916 11.3016 -
Global Peer BEIGENE HKEx 98,300.404 - - 8.0975 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer GENSCRIPT BIO HKEx 33,542.820 201.726 - 9.4592 -
Global Peer 3SBIO HKEx 31,698.826 20.954 25.505 3.1243 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,830.028 45.136 658.146 2.7343 -
Other Global Peers HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), CKLIFE SCIENCES (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), MESOBLAST LTD (ASX), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), KADMON HLDGS INC (NYSE), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), LEE'S PHARM (HKEx), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), DPHARMA (Bursa), PFENEX INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), 22ND CENTURY GROUP INC (NYSE American), BBI LIFE SCI (HKEx), NANOVIRICIDES INC (NYSE American), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), RESAPP HEALTH LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PHYLOGICA LIMITED (ASX), IMUGENE LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), IMMUTEP LTD (ASX), CEL-SCI CORP (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), ORTHOCELL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), PORT (SET), CT ENTERPRISE (HKEx), ARMATA PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENT PACIFIC (HKEx), BIOTRON (ASX), NOVITA HEALTHCARE LTD (ASX), MEMPHASYS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOSINO BIO-TEC (HKEx), RHINOMED LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ORAGENICS INC (NYSE American), EXTRAWELL PHAR (HKEx), ISORAY INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), PROTEOMICS INTL LABORATORIES LTD (ASX), IBIO INC (NYSE American), ANTEO DIAGNOSTICS LIMITED (ASX), IMMURON LIMITED (ASX), PATRYS LIMITED (ASX), Suntar Eco-City^ (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CELLMID LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), REGENEUS LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), CCP TECHNOLOGIES LTD (ASX), BENITEC BIOPHARMA LTD (ASX), MEGASUN (Bursa), AUSTRALIAN PRIMARY HEMP LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HAO WEN HLDGS (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), BIOXYNE LIMITED (ASX), MGRC (Bursa), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), MEDIBIO LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), QT Vascular (SGX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.150
+1.91 %
10 Days -+1.290
+19.20 %
20 Days -+1.475
+22.57 %
Medium Term Return 3 Months -+1.180
+17.28 %
6 Months --0.370
-4.42 %
1 Year --3.630
-31.19 %
Long Term Return 2 Years -+5.220
+187.10 %
3 Years -+6.860
+596.52 %
Annualised Return Annualised --
+90.98 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.150 - 12.620 Change From 1 Year Low +1.860 % Change From 1 Year Low (%) +30.24
Change From 1 Year High -4.610 % Change From 1 Year High (%) -36.53
2 Years Range 2.531 - 24.000 Change From 2 Years Low +5.479 % Change From 2 Years Low (%) +216.48
Change From 2 Years High -15.990 % Change From 2 Years High (%) -66.62
5 Years Range 0.880 - 24.000 Change From 5 Years Low +7.130 % Change From 5 Years Low (%) +810.23
Change From 5 Years High -15.990 % Change From 5 Years High (%) -66.62
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. The company's clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
14 Nov 2019 8.450 8.560 7.950 7.990 1,409,407 -
13 Nov 2019 8.180 8.430 7.910 8.400 1,595,049 -
12 Nov 2019 7.750 8.300 7.680 8.150 2,791,973 -
11 Nov 2019 7.770 7.800 7.560 7.700 870,652 -
08 Nov 2019 7.450 7.880 7.430 7.860 1,091,622 -
07 Nov 2019 7.440 7.890 7.385 7.440 1,356,815 -
06 Nov 2019 7.720 7.850 7.330 7.350 1,433,851 -
05 Nov 2019 6.800 7.900 6.750 7.820 4,283,750 -
04 Nov 2019 6.820 6.930 6.550 6.560 1,192,286 -
01 Nov 2019 6.490 6.800 6.480 6.720 1,431,009 -
31 Oct 2019 6.530 6.550 6.310 6.470 949,303 -
30 Oct 2019 6.620 6.640 6.460 6.520 810,244 -
29 Oct 2019 6.850 6.850 6.585 6.650 1,101,993 -
28 Oct 2019 6.520 6.950 6.520 6.890 1,549,716 -
25 Oct 2019 6.420 6.560 6.390 6.490 1,363,985 -
24 Oct 2019 6.620 6.620 6.430 6.460 578,235 -
23 Oct 2019 6.550 6.710 6.500 6.580 683,261 -
22 Oct 2019 6.590 6.650 6.460 6.580 651,377 -
21 Oct 2019 6.590 6.670 6.460 6.590 824,148 -
18 Oct 2019 6.660 6.800 6.450 6.535 745,562 -
17 Oct 2019 6.610 6.740 6.570 6.700 670,787 -
16 Oct 2019 6.640 6.705 6.530 6.580 658,190 -
Summary
Current 2 Weeks
(01 Nov 2019 to 14 Nov 2019)
6.490 8.560 6.480 7.990 17,456,414 -
Previous 2 Weeks
(18 Oct 2019 to 31 Oct 2019)
6.660 8.560 6.450 6.470 9,257,824 -
4 Weeks from
(20 Sep 2019 to 17 Oct 2019)
7.260 8.560 6.480 6.700 30,661,162 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.